Peter Radovich

CIK 1650131 · PRESIDENT AND COO · last filed 2026-06-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.73M

Companies

3

Total Filings

55

Lifetime Open-Market Net

-$6.85M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MIRM PRESIDENT AND COO 57,260 $99.97 $5.72M -$3.99M 31 2026-06-08
RAIN Director 8,796 $1.16 $10.2K $0 4 2024-01-26
Global Blood Therapeutics, Inc. (GBT) Delisted See Remarks 8,833 $68.49 $605.0K -$2.86M 16 2018-02-16

Recent Filings · Page 6 of 6

55 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2016-10-03 Global Blood Therapeutics, Inc. (GBT) Delisted Grant (A) $0 EDGAR
2016-09-12 Global Blood Therapeutics, Inc. (GBT) Delisted Grant (A) $0 EDGAR
2016-03-14 Global Blood Therapeutics, Inc. (GBT) Delisted Grant (A) $0 EDGAR
2016-02-03 Global Blood Therapeutics, Inc. (GBT) Delisted Grant (A) +1,225 $19.7K EDGAR
2016-01-07 Global Blood Therapeutics, Inc. (GBT) Delisted Buy (P) +12,500 $250.0K EDGAR
Showing 5155 of 55
Page 6 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.